Category: Drug Pricing

Drug Pricing

Drug Pricing

Medicare Negotiations Are Now the Law, but How to Implement Them?

Medicare Negotiations Are Now the Law, but How to Implement Them?

Oct. 18, 2022 – The Centers for Medicare & Medicaid Services (CMS) is beginning to establish a framework for the Medicare drug pricing negotiations mandated in the recently enacted Inflation Reduction Act (IRA), a process that will be complicated and controversial. “Passage of the Inflation Reduction Act – including provisions to mandate Medicare negotiations on […]

Read more

Drug Pricing

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

April 25, 2022 – With drug pricing a hot-button issue as the midterm elections draw near, a recent report from the IQVIA Institute for Human Data Science shines a spotlight on some of the nuances that often are missed when discussing the nuts and bolts of drug spending in the United States. One of the […]

Read more

Categories

Recent Posts

Tags

ACA ad tax Advertising Coalition CDER CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation off-label off-label communication omission of risk OPDP OPDP enforcement PhRMA regulation Risk Information rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines